OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
7.17
-0.43 (-5.66%)
Sep 9, 2026, 4:00 PM EDT - Market closed
OptimizeRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 98.65 | 109.43 | 92.13 | 71.52 | 62.45 | 61.29 | |
Revenue Growth | -5.82% | 18.78% | 28.81% | 14.53% | 1.89% | 41.51% |
Cost of Revenue | 26.42 | 35.83 | 32.75 | 28.62 | 23.48 | 25.65 |
Gross Profit | 72.24 | 73.6 | 59.38 | 42.9 | 38.97 | 35.64 |
Selling, General & Admin | 48.4 | 50.25 | 49.56 | 40.03 | 33.49 | 27.7 |
Operating Expenses | 60.97 | 61.53 | 65.35 | 56.15 | 51.26 | 35.28 |
Operating Income | 11.26 | 12.06 | -5.97 | -13.25 | -12.29 | 0.36 |
Interest Expense | -4.68 | -5.29 | -6.16 | -1.45 | - | - |
Interest & Investment Income | 0.33 | 0.35 | 0.33 | 2.19 | 0.85 | 0.02 |
Other Non Operating Income (Expenses) | 0.2 | 0.2 | 0.15 | 0.5 | - | - |
EBT Excluding Unusual Items | 7.12 | 7.32 | -11.65 | -12.01 | -11.44 | 0.38 |
Merger & Restructuring Charges | - | - | -0.24 | -4.27 | - | - |
Impairment of Goodwill | - | - | -7.49 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | -2.14 | - | - |
Asset Writedown | -0.37 | -0.37 | - | -6.74 | - | - |
Pretax Income | 6.75 | 6.95 | -19.39 | -25.16 | -11.44 | 0.38 |
Income Tax Expense | 2.15 | 1.82 | 0.73 | -7.6 | - | - |
Net Income | 4.6 | 5.13 | -20.11 | -17.57 | -11.44 | 0.38 |
Net Income to Common | 4.6 | 5.13 | -20.11 | -17.57 | -11.44 | 0.38 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 19 | 19 | 18 | 17 | 18 | 17 |
Shares Outstanding (Diluted) | 19 | 19 | 18 | 17 | 18 | 18 |
Shares Change | 3.84% | 3.86% | 6.82% | -3.71% | 0.53% | 19.30% |
EPS (Basic) | 0.25 | 0.28 | -1.10 | -1.03 | -0.64 | 0.02 |
EPS (Diluted) | 0.25 | 0.27 | -1.10 | -1.03 | -0.64 | 0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 18.36 | 18.66 | 4.78 | -7.33 | 10.57 | 0.63 |
Free Cash Flow Per Share | 0.96 | 0.98 | 0.26 | -0.43 | 0.59 | 0.04 |
Gross Margin | 73.22% | 67.25% | 64.45% | 59.98% | 62.40% | 58.14% |
Operating Margin | 11.42% | 11.02% | -6.49% | -18.53% | -19.68% | 0.59% |
Profit Margin | 4.66% | 4.69% | -21.83% | -24.56% | -18.32% | 0.62% |
Free Cash Flow Margin | 18.61% | 17.05% | 5.18% | -10.24% | 16.93% | 1.02% |
EBITDA | 15.55 | 16.39 | -1.65 | -10.85 | -10.27 | 2.33 |
EBITDA Margin | 15.76% | 14.98% | -1.79% | -15.17% | -16.44% | 3.80% |
D&A For EBITDA | 4.29 | 4.33 | 4.33 | 2.4 | 2.02 | 1.97 |
EBIT | 11.26 | 12.06 | -5.97 | -13.25 | -12.29 | 0.36 |
EBIT Margin | 11.42% | 11.02% | -6.48% | -18.53% | -19.68% | 0.59% |
Effective Tax Rate | 31.85% | 26.16% | - | - | - | - |
Advertising Expenses | - | 0.45 | 1.05 | 0.78 | - | - |